BRCA1 in the family: a case description of the psychological implications

American Journal of Medical Genetics

Volumn 71, Issue 1, 1997, Pages 68-71

  Dudokdewtt, A C ^a,b,c,d   Tibben, A ^a,b,c,d   Frets, P O ^a,b,c,d   Meijers Heijboer, E J ^a,b,c,d   Devilee, P ^a,b,c,d   Klijn, J G M ^a,b,c,d   Oosterwijk, J C ^a,b,c,d   Niermeijer, M F ^a,b,c,d  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1; Breast cancer; Family dynamics; Genetic counseling; HBOC; Predictive dna test

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER FAMILY; CANCER SCREENING; EMOTION; FAMILY; GENETIC COUNSELING; HUMAN; MASTECTOMY; OVARIECTOMY; OVARY CARCINOMA; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE;

EID: 0030985267     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. American Society of Human Genetics HS94I: Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Air, J Hum Gunet 55:i-iv.
2. BiesecKer BB, Boennke M, Calzone K, Markel DS, Garber JE, Col,ins FS, Weber BL (1993): Genetic counseling for families with inherited susceplibil'.ty to breast and ovarian cancer. JAMA 269:1970-1974.
3. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT (1995): Women's receptivity to tesung for a genetic susceptibility 10 breast cancer. Am J Public Health 85:1133-1135.
4. Cornelis RS, Vasen HF, Meijers-Heijboer H, Ford B, van Vliet M, van Tilborg AA, Cleton FJ, Klijn JG, Menko FH, Meera Khan P, et al. (1995): Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Hum Genet 95:539-544.
5. DuaokdeWii AC, Meijers-Heijboer EJ, Tiboen A, Frets PC-, Klijn JGM, Devilee P, Niermeijer MF (1994): Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer. Lancet 344:197.
6. DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijooer EJ, Niermeijer MF i 1996): Males al-risk for the BRCA1 gene, the psychological impact. Psycho-Oncol 5:251-257.
7. Easton DF, Bishop DT, Ford D, Crockford GP (1993): Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52: 678-701.
8. Easton DF, Ford D, Bishop DT (1995): Breast and ovarian cancer incidence in BRCAl-mulalion carriers. Breast Cancer Linkage Gonsortium. Am J Hum Genet 56:265-271.
9. Eng C, Stratton M, Ponder B, Murday V, Easton D, Sacks N, Watson M, Eeles R (1994): Familial cancer syndromes. Lancet 343:709-713.
10. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994): Risks of cancer in BRCA1-mutation carriers. Breast Gancer Linkage Consortium. Lancet 343:692-695.
11. Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JG, Vasen HF, Meijers-Heljboer H, et al. ,'1995): Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10(2):208-212.
12. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky Ü, Trew M, Klimek M, Greenberg CR, ElcffM, Thompson LP, et al. (1992): Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42:508515.
13. International Huntington Association and the World Federation of Neurology Research Group on Huntingdon's Chorea (1994): Guidelines for the molecular genetics predictive test, in Huntington's disease. J Med Genet 31:555-559.
14. Kash KM, Holland JC, Halper MS, Miller DG (1992): Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer inst 84:24-30.
15. Kessler S (1994): Predictive testing for Huntington disease: a psychologist's view. Am J Med Genet 54:161-108.
16. Kessler S and Bloch M (1989): Social system responses to Huntinifton disease. Fam Process 28:59-68.
17. Lerrnan C and Schwartz M (1993): Adherence and psychological adjustment among women at nigh risk for breast cancer. Breast Cancer Res Treat 23:145-155.
18. Lerman C, Audrain J, Croyle RT ij.994a): DNA-testing for heritable breast cancer risks: Lessons from traditional genetic counseling. Mini-Series: Advances in behavioral medicine research on breast cancer. An Behavioral Med 16:327-333.
19. Lerman C, Daly M, Masny A, Balshem A (1994b): Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843850.
20. Lerman C, Seay J, Balshem A, Audrain J U995a): Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392.
21. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A ; (1995b): Effects of individualized breast cancer risk counseling: A randomized trial. J Natl Cancer Inst 87:286-292.
22. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H ,1996): BSCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275:1885-1892.
23. Lynch HT, Watson P, Conway TA, Lynch JF. Siominski-Caster SK, Narod SA, Feunteun J, Lenoir G (1993): DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med 155:1979-1987.
24. MacKay CK (19S3): Discussion points to consider in research related to the human genome. Hum Gene Ther 4:477-495.
25. Martindale B il987): Huntington's chorea: Some psychodynamics seen in those at risk and in the responses of the helping professions. 3r J Psychiatry 150:319-323.
26. Mi-u Y, Swensen J, Shattucx-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Coehran C, Bennett LM, Ding W, et al. (1994): A strong candidate for the hreast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
27. Miller SM, Summerton J, Brody DS (1988): Styles of coping with threat: implications for health. J Pers Soc Psychol 54:142-148.
28. Struewing JP, Lerman C, Käse G, Giambarresi TR, Tucker MA (1995): Anticipated uptake ana impact of genetic resting in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prevention 4:169-173.
29. Thies U, Bockei B, Bochdulofsky V (1993): Attitudts of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany. J Med Genet 30:1023-1027.
30. Thomassen R, Tiboen A, Niermeijer MF, van der Does E, van de Kamp JJ, Verhage F (1993): Attitudes of Dutch gênerai practitioners towards presymptomatic DNA-testing For Huntington disease. Clin Genet 43: 63-88.
31. Tibben A, Vegter-van der Vlis M, van de Karap JJ, Roos KA, Rooijmans HG, Frets PG, Verhage F (1990): Testing for Huntington's disease with support for all parties. Lancet 335:553.
32. Tibben A, Frets PG, van de Kamp JJ, Niermeijer MF, Vegter-van der Vlis M, Roos RA, van Ommen GJ, Duivenvoorden HJ, Verhage F (1993): Presymptomatic DNA-testing for Huntlngton disease: pretest attitudes and expeetaiions of applicants and their partners in the Dutch program. Arn J Meet Genet 48:10-16.
33. Tibben A, Stevens M, van der Wert GMWfl, Niermeijer MF, van Duijn CM, van Swieten JC (1997): Preparing for Presymptomatic DNA-testing for early onset Alzheimer Disease/Cerebral Hemorrhage and hereditary Pick Disease. J Meet Genet 34:63-72.
34. Watson M, Murday V, Lloyrî S, Ponder B, Averill D, Eeles R (1995): Genetic testing in breast/ovarian cancer (BRCA1) families. Lancet 346:585.
35. Wiggins S, Whyte P, Huggins il, Adam S, Theiimann J, Bloch M, Sheps SB, Schechter MT, Hayden MR (1992): The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 327:1401-1405.
36. Yalom ID (1980): Existential Psychology New York: Basic Bouks, Inc.